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Upregulation of 5′‑terminal 
oligopyrimidine mRNA translation 
upon loss of the ARF tumor 
suppressor
Kyle A. Cottrell1, Ryan C. Chiou1 & Jason D. Weber1,2*
Tumor cells require nominal increases in protein synthesis in order to maintain high proliferation rates. 
As such, tumor cells must acquire enhanced ribosome production. How the numerous mutations in 
tumor cells ultimately achieve this aberrant production is largely unknown. The gene encoding ARF is 
the most commonly deleted gene in human cancer. ARF plays a significant role in regulating ribosomal 
RNA synthesis and processing, ribosome export into the cytoplasm, and global protein synthesis. 
Utilizing ribosome profiling, we show that ARF is a major suppressor of 5′‑terminal oligopyrimidine 
mRNA translation. Genes with increased translational efficiency following loss of ARF include many 
ribosomal proteins and translation factors. Knockout of p53 largely phenocopies ARF loss, with 
increased protein synthesis and expression of 5′‑TOP encoded proteins. The 5′‑TOP regulators eIF4G1 
and LARP1 are upregulated in Arf- and p53-null cells.
Accelerated cellular division and macromolecular growth of tumors is dependent on robust protein synthesis. 
To meet this need, ribosome biogenesis and translation rates are frequently elevated in cancer  cells1. Increased 
translation in cancer cells is often driven by activation of the mTORC1  pathway1.
Loss of the gene encoding the ARF tumor suppressor is the most common copy number variation in  cancer2. 
ARF is expressed in response to oncogenic stimuli—including the overexpression of Myc, oncogenic Ras and 
chronic activation of the mTORC1-pathway3,4. The canonical function of ARF is to stabilize p53 by sequester-
ing MDM2 in the  nucleolus4–6. In addition to its canonical role, ARF suppresses global protein synthesis and 
ribosome biogenesis by regulating rRNA transcription and  processing7–16. ARF also regulates the translation of 
specific mRNAs, including VEGFA and  DROSHA10,17.
While ARF is known to regulate ribosome biogenesis, the p53-MDM2 axis senses dysregulation of ribosome 
 biogenesis18. Free ribosomal proteins, such as RPL11, bind to MDM2 and lead to stabilization of  p5318. In addi-
tion, p53 is known to repress the activity of mTORC1 during genotoxic  stress19.
The synthesis of ribosomal proteins is tightly regulated by the mTORC1  pathway20. Multiple components of 
the translation machinery, including many ribosomal proteins and some translation factors contain a 5′-terminal 
oligopyrimidine (5′-TOP) motif at the beginning of their  mRNAs21,22. mTORC1 has been shown to enhance 
5′-TOP mRNA translation via two mechanisms; phosphorylation of 4EBP1 and/or  LARP123–28. Phosphorylation 
of 4EBP1 by mTORC1 prevents 4EBP1 from disrupting the interaction of eIF4E and the mRNA cap, and has been 
shown to selectively enhance 5′-TOP mRNA  translation25,26. However, the role of 4EBP1 in regulating 5′-TOP 
mRNA translation has been disputed, as it has been shown that 4EBP1 is dispensable for regulation of 5′-TOP 
mRNAs under some  conditions29. LARP1 has a dual-role in regulating the translation of 5′-TOP mRNAs—act-
ing as a repressor and  enhancer24. As a repressor of 5′-TOP mRNA translation, LARP1 disrupts eIF4E binding 
to the 5′ end of the mRNA, preventing formation of the eIF4F  complex24. Activation of the mTORC1 pathway 
leads to phosphorylation of LARP1 by S6-kinase and  mTORC124. When phosphorylated, LARP1 no longer 
binds to the 5′UTR to repress translation. Phosphorylated LARP1 instead binds the 3′UTR of 5′-TOP mRNAs 
and enhances their  translation24.
Here, we show that ARF selectively regulates the synthesis of ribosomal proteins and translation factors 
containing 5′-TOP motifs within their mRNAs. Knockdown or knockout of ARF caused increased translation 
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of many 5′-TOP mRNAs. This effect of ARF-loss was dependent on p53 expression. Knockout of p53 caused a 
similar increase in the expression of some 5′-TOP mRNA encoded proteins. Finally, we observed upregulation 
of many regulators of 5′-TOP mRNA translation following loss of ARF or p53.
Results
Increased protein synthesis following loss of ARF. ARF has been previously identified as a regu-
lator of global protein  synthesis10,16. To confirm these previous findings, we assessed global protein synthesis 
using wildtype (WT) and Arf−/− mouse embryonic fibroblasts (MEFs). The Arf−/− mouse has been described 
 previously30. In the Arf−/− mice, exon1β of Cdkn2a, the gene encoding both Arf (p19) and Ink4a (p16), has 
been replaced with a neo cassette. This deletion has no effect on INK4A expression while providing a complete 
knockout of Arf30. Polysome profiling of WT and Arf−/− MEFs revealed a shift of rRNA mass towards polysomes 
in Arf−/−, indicating more translation in those cells, Fig. 1a and Supplemental Fig. 1. This result is consistent 
with previous  studies10,16. We further confirmed this observation by measuring the rate of puromycin incor-
poration into nascent peptides in WT and Arf−/− MEFs. Puromycin is a translation elongation inhibitor that is 
incorporated into nascent peptide during protein  synthesis31. Using a puromycin antibody it is possible to detect 
puromyclylated peptides. We observed an increase in puromycylated proteins in Arf−/− MEFs compared to WT 
MEFs, Fig. 1b, further confirming elevated protein synthesis in those cells.
Increased translation efficiency of 5′‑TOP mRNAs upon ARF depletion. Previously ARF has 
been identified to not only regulate translation globally but to specifically regulate the translation of a sub-
set of  mRNAs10,17. To map global translational regulation by ARF we employed ribosome profiling to measure 
changes in translation following ARF depletion. We performed ribosome profiling and RNAseq for WT MEFs 
transduced with either shSCR or shARF in addition to Arf−/− MEFs transduced with shSCR, Fig. 2a. The shRNA 
used to knockdown ARF has been described previously and has no effect on INK4A  expression16. Replicate-
to-replicate comparisons show strong correlations between RNAseq or ribosome profiling replicates (Supple-
mental Fig. 2b). We used DESeq2 to identify differential translation efficiency (TE) as described  previously32. 
Most mRNAs showed no significant difference in TE upon loss of ARF, Fig. 2b,c. However, a subset of mRNAs 
showed a slight but significant increase in translation following ARF depletion by either knockdown with shARF 
or knockout of Arf. There is a significant correlation between fold change of TE following ARF knockdown 
and knockout, Fig. 2d. Gene ontology (GO) analysis of the genes with increased TE following knockout of Arf 
identified multiple GO terms associated with translation, Fig. 2e. A closer look at the genes with the biggest 
increase in TE revealed many ribosomal proteins and translation factors. It has been well established that most 
ribosomal proteins and many translation factors contain a 5′-TOP  motif21,22. Analysis of our ribosome profiling 
results revealed that many of the mRNAs with increased TE are known to contain a 5′-TOP motif, Fig. 2f. 21. 
Furthermore, mRNAs known to contain a 5′-TOP motif show a general increase in TE following knockout of 
Arf, Fig. 2g.
To validate our ribosome profiling findings, we assessed the mRNA and protein abundance of several 5′-TOP 
genes in MEFs following depletion of ARF. By immunoblot we observed increased protein abundance for the 
5′-TOP genes PABPC1, TPT1, EEF2, RPL23A and RPL22, Fig. 3a,b and Supplemental Figs. 3, 4. The increased 
protein abundance measured by immunoblot was generally consistent with the increased TE measured by ribo-
some profiling, Fig. 3d. The antibody used for PABPC1 was raised against a peptide from PABPC1, but may 
cross-react with other PABPCs, as such we have labeled this blot and others ‘PABP’. Because the expression 
of PABPC1 is much higher than that of the other PABPCs (Supplemental Dataset) it likely that most of the 
immunoblot signal is coming from PABPC1. The expression of PABPC1, TPT1, EEF2, RPL23A and RPL22 
Figure 1.  Upregulation of translation following loss of ARF. (a) Polysome profiling showing increased 
polysome peaks in Arf−/− MEFs (b) Puromycin translation assay showing increased protein production in Arf−/− 
MEFs. – untreated, 1 and 2 treatment with puromycin for 1 or 2 min, C indicates cells that were treated with 
cycloheximide prior to puromycin treatment for 2 min.
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was unchanged at the mRNA level, Fig. 3c. Combined with our ribosome profiling results these data support 
increased translation of 5′-TOP mRNAs in ARF-null MEFs. To further validate these findings, we utilized a pre-
viously described 5′-TOP  reporter26. The reporter contains the promoter and 5′-UTR of the 5′-TOP gene EEF2, 
Fig. 3e. The 5′-TOP reporter and a control that has a mutated 5′-TOP motif were transfected in parallel into WT 
or Arf−/− MEFs along with a firefly luciferase control. We observed increased luciferase activity for our 5′-TOP 
reporter in Arf−/− MEFs, Fig. 3f. This contrasts with the 5′-TOP-mutant reporter which had consistent activity 
between WT and Arf−/− MEFs. Analysis of the mRNA abundance of the 5′-TOP reporter revealed no change 
in mRNA expression in Arf−/− MEFs relative to WT, Fig. 3g. This indicates that the increased luciferase activity 
observed for the 5′-TOP reporter is caused by increased translation efficiency—not transcription or RNA stabil-
ity. To provide further evidence we generated a second reporter system; the promoter and 5′UTR from Rpl23a, 
a 5′-TOP containing gene that showed increased TE upon ARF depletion in our ribosome profiling data, was 
cloned upstream of firefly luciferase, Supplemental Fig. 4b. The RPL23A reporter showed increased luciferase 
activity in ARF knockdown and knockout MEFs relative to WT, Supplemental Fig. 4c,d. Together these data 
confirm increased translation efficiency of 5′-TOP containing mRNAs following loss of ARF.
Figure 2.  Ribosome profiling reveals upregulation of 5′-TOP mRNA translation following loss of ARF. (a) 
Immunoblot showing knockdown and knockout of Arf in MEFs. (b) Volcano plot showing Log2 Fold Change 
of TE between WT-shSCR and Arf−/− -shSCR MEFs or WT-shSCR and WT -shARF MEFs (c) Vertical lines 
are Log2 Fold Change of ± 0.5. Horizontal line is FDR corrected p-value of 0.05. (d) Correlation between Fold 
Change of TE following ARF knockout (x-axis) or ARF knockdown (y-axis). (e) Geno ontology terms associated 
with genes that have increased TE following ARF knockout. (f) Venn-diagram showing overlap between 
mRNAs with increased TE and the presence of a 5′-TOP motif. (g) Violin plot showing the TE of mRNAs 
known to contain a 5′-TOP motif versus those that are not known to contain the  motif21. *** p-value < 0.00001; 
Hypergeometric test (f) or two-tailed t-test (g).
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Increased translation efficiency of 5′‑TOP mRNAs upon ARF loss is dependent on p53. ARF 
is a well-known activator of  p534,5. To test whether p53 is required for ARF-dependent regulation of 5′-TOP 
mRNA translation we performed some of the experiments described above in p53−/− MEFs. Knockdown of ARF 
in p53−/− MEFs had no effect on protein abundance of the evaluated 5′-TOP genes, Fig. 4a,b and Supplemental 
Fig. 5b. Furthermore, knockdown of ARF had no effect on the translation of the EEF2 5′-TOP reporter or the 
RPL23A reporter, Fig. 4c and Supplemental Fig. 5c. There was no difference in polysome abundance between 
shSCR and shARF transduced p53−/− MEFs indicating no changes in total protein synthesis, Fig. 4d and Supple-
mental Fig. 5a. However, there were some changes in the abundance 40S and 60S ribosomal subunits based on 
variations in peak heights. This observation mirrored that seen following knockout of Arf in WT MEFs. These 
findings indicate that p53 is required for ARF-dependent translational regulation of 5′-TOP mRNAs.
Loss of ARF modestly affects the expression or activity of 5′‑TOP regulators. The mTOR path-
way is known to regulate 5′-TOP mRNAs through the phosphorylation of LAPR1, which changes LARP1 from 
a repressor of 5′-TOP mRNA translation to an  enhancer23,24,27,28. LARP1 is phosphorylated by mTORC1 and 
the mTORC1 substrate S6-kinase24. Immunoblot analysis of mTORC1 pathway activation in WT and ARF-null 
MEFs revealed a slight, though inconsistent and non-significant increase in mTORC1 activity, Fig.  5a,b and 
Supplemental Fig. 7a. S6-kinase showed the largest increase, though statistically insignificant, in phosphoryla-
tion following ARF depletion, indicating LARP1 may be phosphorylated in those cells. However, inhibition of 
Figure 3.  Upregulation of 5′-TOP mRNA translation following loss of ARF. (a) Immunoblot analysis showing 
increased protein abundance of PABP, TPT1, RPL23A, EEF2 and RPL22. (b) Quantitation of blots in panel (a). 
Total protein was used for normalization. Mean ± SD, n = 6. (c) qPCR shows no change in mRNA expression of 
5′-TOP mRNAs. Mean ± SD, n = 4. (d) The average fold change of TE from two ribosome profiling replicates is 
shown for PABPC1, TPT1, RPL23A, EEF2 and RPL22. (e) Schematic of the luciferase reporters used in panels 
(f,g). (f) Luciferase activity of a 5′-TOP reporter is increased in Arf−/− MEFs (Arf-KO). Luciferase activity was 
normalized to firefly luciferase transfection control and set relative to WT. Mean ± SD, n = 3. (g) qPCR shows 
no increase in mRNA expression of the 5′-TOP reporter. Normalized to firefly luciferase transfection control. 
Mean ± SD, n = 3. *, p-value < 0.05, ** p-value < 0.01; two-tailed t-test with Bonferoni correction.
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S6-kinase had no effect on the expression of 5′-TOP encoded proteins, Supplementary Fig.  9. This result is 
consistent with previous studies that have shown S6-kinase to be dispensable for regulation of 5′-TOP mRNA 
 translation33. Interestingly, we observed increased phosphorylation of S6-kinase, but no increased phosphoryla-
tion of other mTORC1 markers following ARF-knockdown in p53−/− MEFs, Supplemental Fig. 6a,b. Treatment 
with the mTOR inhibitor rapamycin was employed to assess the importance of mTORC1 pathway activity in 
Arf−/− MEFs. Consistent with previous reports, cells treated with rapamycin show reduced mTOR autophospho-
rylation and reduced expression of the 5′-TOP encoded proteins RPL22, PABPC1 and TPT1, Fig. 5c,d 34,35. These 
results show that mTORC1 activity is required for maximal expression of 5′-TOP mRNAs in ARF-null MEFs.
mTORC1 has been shown to enhance 5′-TOP translation through phosphorylation of  4EBP125. There was 
a slight but insignificant increase in p-4EBP1 levels upon ARF knockdown, but no change upon knockout of 
ARF, Fig. 5a,b and Supplemental Fig. 7a. However, there was also an increase in total 4EBP1 levels upon ARF 
knockdown, Fig. 5a,b and Supplemental Fig. 7b. As unphosphorylated 4EBP1 is a translational repressor, the 
increased expression of 4EBP1 upon ARF knockdown is unlikely to contribute to increased 5′-TOP translation. 
The expression of eIF4E was unchanged upon knockout or knockdown of ARF, Fig. 5a,b and Supplemental 
Fig. 7c-d.
Maximal translation of 5′-TOP mRNAs is dependent on eIF4G1  expression26. Immunoblot analysis revealed 
increased eIF4G1 expression in ARF-null MEFs, Fig. 5e,f and Supplemental Fig. 8. A similar increase was 
observed in p53−/− MEFs following ARF-knockdown, Supplementary Fig. 6c,d. We attempted to overexpress 
eIF4G1 in WT MEFs via lentiviral transduction, but due to the size of the coding sequence the transduction 
efficiency was extremely low (data not shown). As such, we took the reverse approach and knocked-down eIF4G1 
in Arf −/− MEFs. Knockdown of eIF4G1 caused a slight reduction of protein expression for several 5′-TOP genes 
Figure 4.  5′-TOP expression is unaffected by ARF knockdown in p53−/− MEFs. (a) Immunoblot analysis 
showing no change in protein abundance of PABPC1, TPT1 and RPL22 following ARF knockdown in p53−/− 
MEFs. (b) Quantitation of blots in panel (a). Total protein was used for normalization. Mean ± SD, n = 3. (c) 
No change in luciferase activity of a 5′-TOP reporter following ARF knockdown in p53−/− MEFs. Luciferase 
activity was normalized to Renilla luciferase transfection control and set relative to shSCR. Mean ± SD, n = 3. (d) 
Polysome profiling showing no change in polysome peaks in p53−/− MEFs following knockdown of ARF.
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at 4 days post transduction, Fig. 5g,h, and Supplemental Fig. 8b. These data suggest that increased eIF4G1 
expression is unlikely to be driving increased translation of all 5′TOP mRNAs, but may have a role in regulating 
specific mRNAs like TPT1.
LARP1 is a known regulator of 5′-TOP mRNA  translation24,27,28. Immunoblot analysis of WT and ARF-null 
MEFs showed increase protein abundance for LARP1, Fig. 5i,j and Supplemental Fig. 8c. There was no increase 
in LARP1 mRNA expression in ARF-null MEFs relative to WT MEFs, Fig. 5j. Knockdown of ARF in p53−/− MEFs 
had no effect on LARP1 expression, Supplementary Fig. 5e,f. Given the dual role of LARP1 as both an enhancer 
and repressor of 5′-TOP mRNA  translation24 it is possible that elevated expression of LARP1 in this context 
could drive 5′-TOP mRNA translation. However, knockdown of LARP1 had little to no effect on the expression 
of several 5′-TOP genes in Arf−/− MEFs, Fig. 5k,l. Only one of the two shRNAs targeting LARP1 had a significant 
effect on expression but for only one of the 5′-TOP genes assessed – TPT1. These findings indicate that elevated 
LARP1 expression is not likely to be the driving force behind increased 5′-TOP mRNA translation following 
loss of ARF, though it may have a role in the regulation of specific 5′-TOP mRNAs.
Loss of p53 causes upregulation of 5′‑TOP mRNAs. Having observed a role for ARF in regulation 
5′-TOP mRNA translation, we next sought to determine if p53, which is tightly coupled to ARF expression, has 
a similar role. Polysome profiling revealed increased translation in p53−/− MEFs, as indicated by higher poly-
some peaks, Fig. 6a and Supplemental Fig. 10a-b. We used immunoblot analysis and qPCR to determine the 
protein and mRNA expression of some of the 5′-TOP genes studied above. We observed an increase in protein 
expression for three of the 5′-TOP genes (PABPC1, EEF2 and TPT1) in p53−/− MEFs, there was no increase in 
RNA expression, Fig. 6b,e,f, and Supplemental Figs. 10 and 11. This is consistent with our findings from ARF-
null MEFs. Analysis of the luciferase reporters described above showed increased activity for the EEF2 5′-TOP 
reporter and the RPL23A reporter in p53−/− MEFs, Fig. 6c and Supplemental Fig. 10c, without any increase in 
mRNA expression, Fig. 6d and Supplemental Fig. 10d.
Consistent with Arf knockout, immunoblot analysis of WT and p53−/− MEFs revealed an increase in LARP1 
and eIF4G1 expression, Fig. 6b,g,h, and Supplemental Figs. 10–11. Immunoblot analysis of mTORC1 activity 
showed no changes in phosphorylation level of mTOR itself and only modest increases in phosphorylation of 
downstream pathway components following knockout of p53, Fig. 6b,I, and Supplemental Fig. 11. Knockout of 
p53 had no effect on 4EBP1 expression or phosphorylation, Fig. 6b,i. Unlike knockout of Arf, we did observe 
increased expression of eIF4E, Fig. 6b,i, and Supplemental Fig. 11.
Discussion
Together these data fit well with what is known about the functions of ARF in ribosome biogenesis. ARF is known 
to repress ribosome biogenesis by affecting rRNA transcription, processing and nuclear  export7–16. Changes in 
5′-TOP mRNA translation upon loss of Arf would help to balance concomitant changes in rRNA production 
by providing increases in the necessary ribosome subunit proteins. Increased translation of 5′-TOP mRNAs 
following loss of the ARF tumor suppressor provides a missing mechanism for the increased rates of translation 
and ribosome biogenesis seen in many human  cancers36.
Previously, it has been shown that loss of ARF caused enhanced translation of two mRNAs: DROSHA and 
 VEGFA10,17. We did not observe any significantly increased translation efficiency for either DROSHA or VEGFA 
following knockdown or knockout of ARF. One possible explanation for the discrepancy regarding VEGFA could 
be the cell line used. The VEGFA experiments were performed in established NIH3T3 and Arf/p53 DKO MEFs 
with overexpression of ARF, not knockdown/knockout17.
While many of the functions of ARF in regulating ribosome biogenesis are p53-independent, we show here 
that the regulation of 5′-TOP mRNAs by ARF requires p53 expression. Furthermore, we show that loss of p53 
partially phenocopies the effects of ARF depletion on 5′-TOP mRNA translation. These data suggest that canoni-
cal ARF-MDM2-p53 axis plays an important role in 5′-TOP mRNA translation. Interestingly, free ribosomal 
proteins, such as RPL11, are known to activate p53 through binding  MDM218. Elevated expression of 5′-TOP con-
taining ribosomal proteins following loss of p53 would complete a feedback loop. Recently it has been shown that 
the cyclin-dependent kinase CDK1 can phosphorylate LARP1 and 4EBP1, and has a general role in enhancing 
 translation37. As p53 represses CDK1 activity through transcriptional upregulation of p21 (Cdkn1a), the ability 
Figure 5.  The expression and activity of 5′-TOP mRNA regulators following loss of tumor suppressors. 
(a) Immunoblot analysis showing activity of mTORC1 in WT and ARF-null MEFs and quantified in (b). 
p-mTOR = p-S2484, p-S6K = p-T389 (p70), p-S6 = p-S240/S244, p-4EBP1 = p-T37/T46. Total protein was 
used for normalization. Mean ± SD, n = 4–5 (c) Immunoblot analysis showing expression of 5′-TOP mRNA 
encoded proteins following treatment with rapamycin (Selleck Chemicals) and quantified in (d). Arf−/− MEFs 
were treated with 5 nM rapamycin for 4 days. Total protein was used for normalization. Mean ± SD, n = 3. 
(e) Immunoblot analysis showing increased expression of eIF4G1 in ARF-null MEFs. f Quantitation of blot 
in (e) and qPCR for eIF4G1, total protein was used for normalization of immunoblot, Mean ± SD, n = 4. (g) 
Immunoblot analysis showing the effect of eIF4G1 knockdown on 5′-TOP gene expression. h Quantitation of 
blot in (g), total protein was used for normalization of immunoblot, Mean ± SD, n = 3. (i) Immunoblot analysis 
showing increased expression of LARP1 in ARF-null MEFs. (j) Quantitation of blot in i and qPCR for LARP1, 
total protein was used for normalization of immunoblot, Mean ± SD, n = 4. (k) Immunoblot of Arf−/− MEFs 
following knockdown of LARP1 with two different shRNAs. (l) Quantitiation of blot in (k), total protein was 
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of CDK1 to phosphorylate LARP1 and 4EBP1 could contribute to increased 5′-TOP translation following loss 
of p53 or ARF—though we did not see evidence of increased 4EBP1 phosphorylation (relative to total 4EBP1) 
following loss of p53 or ARF. In support of this hypothesis, we observed decreased RNA expression of p21 upon 
knockout of Arf (Supplementary Dataset). The connection between ARF, p53, p21, CDK1 and regulation of 
5′-TOP translation deserves further investigation.
It is unclear what factors drive increased 5′-TOP mRNA translation following loss of ARF. We observed 
increased expression and activity for several regulators of 5′-TOP mRNA translation. Depletion of ARF had 
little effect on mTORC1 activity, though there was a slight and non-significant increase in phosphorylation of 
some pathway components. By inhibiting mTOR with rapamycin we showed that maximal expression of 5′-TOP 
encoded proteins requires mTOR activity. mTORC1 enhances 5′-TOP mRNA translation through phosphoryla-
tion of LARP1. LARP1 acts to balance 5′-TOP mRNA translation through inhibition of translation when dephos-
phorylated and enhancing translation when  phosphorylated24. Dephosphorylated LARP1 binds the 5′-TOP motif 
and blocks binding of eIF4E, thus blocking assembly of the eIF4F  complex27. A component of the eIF4F complex, 
eIF4G1 has also been shown to be required for 5′-TOP  translation26. We observed increased expression of both 
eIF4G1 and LARP1 following depletion of ARF. Because of technical limitations described above, it is difficult 
to assess the direct role of eIF4G1 in regulating endogenous 5′-TOP mRNAs via overexpression in this system. 
Knockdown of eIF4G1 caused a slight and somewhat inconsistent reduction in 5′-TOP gene expression at the 
protein level. Knockdown of LARP1 in Arf−/− MEFs had only modest effects on 5′-TOP mRNA expression, with 
one shRNA causing a significant reduction in the expression of the 5′-TOP mRNA encoded protein TPT1. This 
suggests that at least for TPT1, LARP1 may modestly enhance translation. Because phosphorylated LARP1 is 
known to enhance 5′-TOP mRNA translation, this result is consistent with active mTORC1 in Arf−/− MEFs. 
Increased 5′-TOP mRNA translation could be driven by the combinatorial effect of small increases in eIF4G1 
and LARP1 expression, as well as increased mTORC1 activity. A more intriguing possibility is that an unknown 
factor—downstream of ARF—controls 5′-TOP mRNA translation. Further work is needed to elucidate this 
pathway. Because many 5′-TOP encoded proteins are essential components of the translation machinery, it is 
important to understand how loss of ARF can drive 5′-TOP mRNA translation and global protein synthesis. 
A complete understanding of this pathway may lead to future therapeutic interventions aimed at reducing the 
protein synthesis capacity of ARF-null tumors.
Regulation of 5′-TOP mRNA translation independent of mTORC1 has been recently observed in mouse liver. 
Knockdown of the translation elongation factor eEF2 increased the translation efficiency of 5′-TOP containing 
mRNAs, without any change in mTORC1  activity38. The findings described here and those from knockdown of 
eEF2 in mouse liver suggest that there is another pathway regulating 5′-TOP mRNA translation.
One potential factor driving increased 5′-TOP translation in p53−/− MEFs could be the cap-binding protein 
eIF4E. We observed a slight increase in eIF4E expression upon p53 knockout, however the same was not true 
following ARF depletion. The affinity of eIF4E for the mRNA cap can be influenced by cap-proximal sequences. 
In fact, 5′-TOP motif containing sequences are sensitive to reductions in eIF4E levels and eIF4E has a lower 
affinity for RNAs containing 5′-TOP  motifs39. Future studies are needed to explore the connection between p53, 
eIF4E and 5′-TOP mRNA translation.
The observation that eIF4G1 and LARP1 are upregulated upon ARF depletion deserves further investiga-
tion. Both eIF4G1 and LARP1 were upregulated at the protein level upon loss of ARF or p53, while there was 
no change at the mRNA level. From our ribosome profiling data, we know that neither eIF4G1 nor LARP1 are 
translationally upregulated. These data suggest that the half-life of LARP1 and eIF4G1 proteins may be extended 
upon ARF or p53 depletion. Upregulation of LARP1 has been seen in many  cancers40–42. Additionally, eIF4G1 
is upregulated in many breast  cancers43,44. As deletion of Arf is a common occurrence in cancer, exploring the 
co-occurrence of Arf-loss and increased LARP1 or eIF4G1 expression seems warranted.
Materials and methods
Cell culture. Mouse embryonic fibroblasts (MEFs) were harvested previously from WT (B6129SF2/J), Arf 
−/− (B6.129X1-Cdkn2atm1Cjs/KaiJ), p53flox/flox (FVB.129-Trp53tm1Brn). MEFs were cultured in Dulbecco’s modified 
Eagle’s medium (DMEM) (Hyclone) with 10% fetal bovine serum (Invitrogen), 2  mM glutamine (Hyclone), 
0.1 mM nonessential amino acids (Hyclone), 1 mM sodium pyruvate (Hyclone), and 2 μg/ml gentamicin (Invit-
rogen). Low passage MEFs, between 1–4 (WT or p53f./f) and 1–7  (ARF−/−), were used for all experiments.
Figure 6.  Upregulation of 5′-TOP mRNAs in p53−/− MEFs. p53fl/fl MEFs were transduced with control 
AAV-LacZ or AAV-Cre to knockout p53. (a) Polysome profiling showing increased polysome peaks following 
knockout of p53 (Cre). (b) Immunoblot analysis showing protein abundance of 5′-TOP encoded proteins 
(TPT1, RPL22, RPL23A, EEF2 and PABPC1) and 5′-TOP regulators (eIF4G1, LARP1, eIF4E and mTORC1) 
following knockout of p53 (AAV-Cre). (c) Luciferase activity of a 5′-TOP reporter is increased in p53−/− MEFs. 
Luciferase activity was normalized to firefly luciferase transfection control and set relative to LacZ control. 
Mean ± SD, n = 3. (d) qPCR shows no increase in mRNA expression of the 5′-TOP reporter. Normalized to 
firefly luciferase transfection control. Mean ± SD, n = 3. (e) Quantitation of blots in panel (b) for TPT1, RPL22, 
RPL23A, EEF2 and PABPC1. Total protein was used for normalization. Mean ± SD, n = 3–7. (f) qPCR shows no 
change in mRNA expression of 5′-TOP mRNAs following knockout of p53. Mean ± SD, n = 6. (g) Quantitation 
of blot in (b) and qPCR for LARP1. Mean ± SD, n = 7(protein), 6(RNA). (h) Quantitation of blot in (b) and 
qPCR for eIF4G1. Mean ± SD, n = 6(protein), 6(RNA). (i) Quantitation of blot in (b) and for mTORC1 pathway. 
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Viral production and transduction. Lentivirus was produced by Lipofectamine 2000 (Inivitrogen) trans-
fection of 293 T cells with pCMV-VSV-G, pCMV-ΔR8.2, and pLKO.1-puro for shRNAs. Virus was harvested 
48 h post-transfection. Cells were transduced with lentivirus for 16 h in the presence of 10 µg/mL protamine 
sulfate. The cells were selected with puromycin at 2 µg/mL for two days. The sequences for the shRNA-scramble 
(shSCR) and shRNA-ARF (shARF) were described and validated  previously16. LARP1 and eIF4G1 shRNAs were 
purchased from Millipore-Sigma: LARP1 shRNA-1: 5′-CCG GGA GTC TCC AAA CTA CCG AAA TCT CGA GAT 
TTC GGT AGT TTG GAG ACT CTT TTTG-3′, LARP1 shRNA-2: 5′-CCG GGG ACA GAC CTA GAG TAC TAA GCT 
CGA GCT TAG TAC TCT AGG TCT GTC CTT TTTG-3′, eIF4G1 shRNA-1: 5′-CCG GCG GAT GTT CTT TGA TGC 
TCT ACT CGA GTA GAG CAT CAA AGA ACA TCC GTT TTTG-3′, eIF4G1 shRNA-2: 5′-CCG GGC GAT GTG TCT 
TGA GCT AAT ACT CGA GTA TTA GCT CAA GAC ACA TCG CTT TTTG-3′, eIF4G1 shRNA-3: 5′-CCG GCA CCG 
AGA ACA TAT TAA AGT ACT CGA GTA CTT TAA TAT GTT CTC GGT GTT TTTG-3’.
Measurement of bulk translation. For polysome profiling, translation was inhibited by the addition of 
50 µg/mL cycloheximide for 5 min at 37 °C in culture media. The cells were then washed with PBS, trypsinized 
and resuspened in culture media. The cells were pelleted and washed with PBS prior to lysis in polysome lysis 
buffer (20 mM Tris pH 7.26, 130 mM KCl, 10 mM  MgCl2, 2.5 mM DTT, 0.5% NP-40, 0.2 mg/mL heparin, 0.5% 
sodium deoxycholate, 50 µg/mL cycloheximide and 200 units/mL RNasin (Invitrogen)). Lysis occurred over 
10 min on ice prior to clarification at 8000 g for 10 min at 4 °C. The absorbance at 260 nm was determined for 
each sample and an equal number of absorbance units for each sample was overlaid onto a 10–50% sucrose gra-
dient made with sucrose gradient buffer (10 mM Tris pH 7.26, 60 mM KCl, 10 mM  MgCl2, 1 mM DTT, 0.1 mg/
mL heparin, 10 µg/mL cycloheximide). The gradients were subjected to ultracentrifugation at 36,000 rpm for 3 h 
at 4 °C. A Teledyne ISCO fractionation system with UV detector was used to determine absorbance at 254 nm 
along the gradient.
For measurement of translation rates by puromycin incorporation, MEFs were treated with 10 µM puromycin 
at room temperature for the times indicated. As a control, cells were also treated with 100 µg/mL cycloheximide 
for 5 min at 37 °C prior to addition of puromycin. Immediately following treatment, the cells were washed with 
1 × PBS containing 100 µg/mL cycloheximide to inhibit further puromycin labeling. The cells were harvested 
and lysed in RIPA buffer with 1 × HALT (Pierce) and 100 µg/mL cycloheximide. Immunoblot was performed as 
described below with anti-puromycin antibody (Developmental Studies Hybridoma Bank, University of Iowa).
Plasmid construction. The 5′-TOP reporter for mouse Rpl23a was made by PCR amplification of a 
region encompassing 500 bp upstream of the annotated transcription start site to the start codon using prim-
ers RPL23A Promoter Forward: 5′- GTA CCT CGA GGA GCT ATA AAG GGA AAC CCT GTCTC -3′ and RPL23A 
5′UTR Reverse: 5′- GTA CCC ATG GTG CTT GGC TGA AAA GGA TGG CCC-3′. The PCR product was digested 
with XhoI and NcoI and ligated into pGL3-control (Promega). The resulting plasmid, pGL3-RPL23A-FF, was 
confirmed by Sanger sequencing.
To make pGL3-Renilla-deltaFF, Renilla luciferase was PCR amplified from pMT-DEST48-FLP45 with Renilla 
Luciferase Forward: 5′-TGG AAG CTT GGC ATT CCG GTA CTG TTG GTA AAG CCA CCA TGA CTT CGA AAG TTT 
ATG-3′ and Renilla Luciferase Reverse: 5′-TGG AAG CTT TTA TTA TTG TTC ATT TTT GAG AAC-3′ and digested 
with HindIII (New England Biolabs, NEB). Renilla luciferase was then ligated into pGL3-Control digested Hin-
dIII (NEB) to make pGL3-Renilla-FF. To remove the firefly luciferase coding sequence, the plasmid was digested 
with NarI and XbaI (NEB), subsequently the ends were blunted with Klenow (NEB) and the plasmid was ligated. 
The resulting plasmid pGL3-Renilla-deltaFF was confirmed by Sanger sequencing.
Transfection of MEFs and luciferase assay. The EEF2 (pIS1-Eef25UTR-renilla) and EEF2-mutant 
(pIS1-Eef25UTR-TOPmut-renilla) reporters were purchased from Addgene and have been described 
 previously26. The day before transfection 1 × 105 cells were plated per well in a six well dish. For transfection of 
the EEF2 reporters, the cells were transfected with Fugene6 (Promega) and 1 µg each of either pIS1-Eef25UTR-
renilla or pIS1-Eef25UTR-TOPmut-renilla and pGL3-Control. After 24  h the cells were washed briefly with 
1 × PBS prior to measurement of luciferase activity by Dual Luciferase Reporter Assay (Promega). For transfec-
tion of the RPL23A or SV40 reporters, the cells were transfected with Fugene6 and 1 µg each of either pGL3-
control (firefly luciferase with SV40 promoter) or pGL3-RPL23A and pGL3-Renilla-deltaFF. After 24 h the cells 
were washed briefly with 1 × PBS prior to measurement of luciferase activity by Dual Luciferase Reporter Assay.
Ribosome profiling and RNAseq. For RNAseq, total RNA was isolated from the appropriate cells using 
the Direct-zol RNA MiniPrep (Zymo) with Trizol (Invitrogen) for initial cell lysis. Contaminating genomic DNA 
was removed by treatment with Turbo DNA-free Kit per the manufacturers protocol (Invitrogen). The RNA 
concentration was determined by Qubit RNA BR Assay (Invitrogen) and ribosomal RNA was removed using the 
RiboZero Gold rRNA Removal Kit (Illumina) per the manufacturers protocol.
The ribo-depleted RNA (10 µL) was then fragmented by adding one volume of 2 × Fragmentation Buffer 
(0.5 M EDTA, 0.1 M  Na2CO3, 0.1 M  NaHCO3) and incubating at 95 °C for 20 min. Fragmentation was inhibited 
by the addition of 280 µL of Stop Solution (3 M NaOAc pH 5.5, 15 mg/mL GlycoBlue (Invitrogen)). The RNA 
was the precipitated by the addition of ethanol. The RNA was resuspended in 10 mM Tris pH 8.0 and resolved 
on a 15% acrylamide Urea-TBE gel (Bio-Rad). A region containing fragments between 17–34 nt (the same size 
as those isolated for ribosome  profiling46) was excised and extracted overnight in RNA Extraction buffer (0.3 M 
NaOAc pH 5.5, 1 mM EDTA and 0.25% Sodium dodecylsulfate). The extracted RNA was precipitated by ethanol 
precipitation and subsequently used for sequencing library preparation as described below.
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Ribosome footprinting was performed as described  previously46, with the use of RNase T1 (Thermo Scientific) 
instead of RNase I for the footprinting step, see Supplemental Fig. 2a. The lysates were treated with 700 units 
of RNase T1 for 1 h at room temperature with gentle mixing. For both ribosome profiling and RNAseq, a small 
amount of yeast lysate was spiked-in to the lysis buffer for later normalization. We chose not to use the yeast 
spike-in for normalization as the replicate-to-replicate comparisons were weak (data not shown).
Following purification of the RNA footprints, sequencing library production was carried out for both the 
fragmented total RNA and ribosome footprints using the previously described  protocol46. The RNAseq and 
ribosome profiling libraries were multiplexed and sequenced on a HiSeq 3000 (Illumina) by the Washington 
University Genome Technology Access Center.
Data and code availability. Raw sequencing reads are available at https ://www.ncbi.nlm.nih.gov/geo 
(GSE156749). Scripts used for analysis of differential expression and TE are available at GitHub (https ://githu 
b.com/cottr ellka /ARF_5TOP). The DESeq2 results (see below) for Fold Change of TE and RNA are available in 
the Supplemental Dataset.
Analysis of sequencing data. The sequences for the linkers and reverse transcriptase primer used in 
this study are available in the Supplementary Information. The ribosome profiling and RNAseq reads were pro-
cessed to remove short reads, reads lacking the sequencing adapter and adapter only reads using fastx_clipper47 
(fastx_clipper -a AGA TCG GAA GAG CAC ACG TCT GAA -c -n -v -l 13). Reads were split by barcodes intro-
duced by the linkers using fastx_barcode_spliter (example: –bcfile Barcodes.txt –prefix/Results/–suffix_ribo.
fastq–eol < riboseq_trimmed_umi_trimmed.fastq). Barcodes and other sequences introduced during library 
production were removed by umi-tools48 (to remove UMIs: umi_tools extract –bc-pattern = NNNNNXXXXX 
–3prime) and cutadapt (to remove barcodes: cutadapt –cut -5)49. Sequencing reads mapping to rRNA or ncR-
NAs were removed using Bowtie250 (example: bowtie2 rrna_seqs results.fastq –un results_norrna.fastq -S nor-
rna_results). The processed reads were then aligned to the mouse genome (UCSC, mm10) using TopHat51 
(example: tophat –no-novel-juncs –output-dir dir/ –GTF genes.gtf mm10/Sequence/Bowtie2Index/genome 
results_norrna_notrna_noncrna.fastq). Read counts of those aligning to the coding sequence of each gene 
were then determined by HTSeq52 (example: htseq-count -t CDS accepted_hits.sam genes.gtf > htseq_results.
txt). Differential TE was determined using DESeq2 in which the design included an interaction term for assay 
and condition (~ assay + condition + assay:condition), this allows for determining differential TE via a ratio of 
ratios (treatment_RiboSeq/control_Riboseq)/(treatment_RNAseq/control_RNAseq)32,53 (see GitHub repository 
above for scripts used).
For classification of 5′-TOP genes, we used a previously described list of known 5′-TOP genes which is avail-
able in Supplementary  Information21.
Gene ontology (GO) analysis was performed using the PANTHER Over Representation test via web browser 
http://geneo ntolo gy.org/ 54–56. For this analysis, the annotation file used was GO version: 2020–03-23. Significance 
was determined by Fisher Exact test and multiple-testing correction was performed by FDR. Genes with fold 
change of TE > 0 and FDR adjusted p-value of < 0.05 where used to identify enriched GO terms.
Immunoblot. Cell pellets were lysed and sonicated in RIPA Buffer (50 mM Tris pH 7.4, 150 mM NaCl, 1% 
Triton X-100, 0.1% sodium dodecyl sulfate and 0.5% sodium deoxycholate) with 1 × HALT Protease Inhibi-
tor (Pierce). Seventy-five micrograms of protein lysate were resolved on 4–12% TGX Acrylamide Stain-Free 
gels (Bio-Rad). Stain-Free gels were imaged prior to transfer to PVDF membrane (Millipore). The blots were 
then probed with the appropriate primary antibodies: Abcam PABP (ab21060); Bethyl—GAPDH (A300-641A), 
LARP1 (A302-087A), EEF2 (A301-688A), RPL23A (A303-932A-T); Cell Signaling Technologies—TPT1(5128), 
p-MTOR (2971), p-S6 (2215S), p-S6K (9205S), p-4EBP1 (2855S), eIF4G1 (2858), p53 (2524S), eIF4E (9742S), 
4EBP1 (9452S); Santa Cruz Biotechnology—ARF (sc-32748), RPL22 (sc-136413), University of Iowa, DSHB—
puromycin. Primary antibodies were detected with horseradish-peroxidase conjugated secondary antibodies 
(Jackson ImmunoResearch) and detection was carried out with Clarity Western ECL Substrate (Bio-Rad).
Quantitative PCR. Total RNA was isolated using the Nucleospin RNA (Macherey–Nagel) with on column 
DNase treatment. Reverse transcription to make cDNA was performed with iScript Supermix (Bio-Rad). For 
qPCR the primers listed in the Supplementary Information were used with iTaq SYBR Green (Bio-Rad). Fold 
change in RNA expression was determined by the ΔΔCt method with normalization to PSMA5, TOMM20 and 
ATP5B. The normalization genes were chosen based on steady expression across all samples as measured by 
RNA-seq. For qPCR of the luciferase reporters: RNA was treated with the restriction enzyme AluI for 30 min at 
37 °C in 1 × Turbo DNase Buffer (Thermo Fisher). After treatment 1 µL of Turbo DNase (Thermo Fisher) was 
added and remaining DNA was digested for 30 min at 37 °C. Turbo DNase was removed using the Turbo DNA-
Free Kit (Thermo Fisher) and the RNA was used for cDNA synthesis as above, with the addition of a 20 min 
incubation at 80 °C following first strand synthesis to inhibit the restriction enzyme. This approach allowed for 
complete removal of plasmid DNA from the RNA sample as determine by qPCR of a no-reverse transcriptase 
control reaction (data not shown). Quantitative PCR was performed as above using Renilla and firefly luciferase 
qPCR primers (Supplementary Information). Fold change in firefly (RPL23A reporters) or Renilla (EEF2 report-
ers) luciferase RNA was determined by the ΔΔCt method with normalization to Renilla (RPL23A reporters) or 
firefly (EEF2 reporters) luciferase, respectively.
12
Vol:.(1234567890)
Scientific Reports |        (2020) 10:22276  | https://doi.org/10.1038/s41598-020-79379-8
www.nature.com/scientificreports/
Received: 11 May 2020; Accepted: 8 December 2020
References
 1. Robichaud, N., Sonenberg, N., Ruggero, D. & Schneider, R. J. Translational control in cancer. Cold Spring Harbor Perspect. Biol. 
11, 254–266 (2019).
 2. Zack, T. I. et al. Pan-cancer patterns of somatic copy number alteration. Nat. Genet. 45, 1134–1140. https ://doi.org/10.1038/ng.2760 
(2013).
 3. Miceli, A. P., Saporita, A. J. & Weber, J. D. Hypergrowth mTORC1 signals translationally activate the ARF tumor suppressor 
checkpoint. Mol. Cell. Biol. 32, 348–364. https ://doi.org/10.1128/MCB.06030 -11 (2012).
 4. Sherr, C. J. & Weber, J. D. The ARF/p53 pathway. Curr. Opin. Genet. Dev. 10, 94–99 (2000).
 5. Weber, J. D., Taylor, L. J., Roussel, M. F., Sherr, C. J. & Bar-Sagi, D. Nucleolar Arf sequesters Mdm2 and activates p53. Nat. Cell. 
Biol. 1, 20–26. https ://doi.org/10.1038/8991 (1999).
 6. Weber, J. D. et al. Cooperative signals governing ARF-mdm2 interaction and nucleolar localization of the complex. Mol. Cell. Biol. 
20, 2517–2528 (2000).
 7. Qi, Y. et al. p19ARF directly and differentially controls the functions of c-Myc independently of p53. Nature 431, 712–717. https 
://doi.org/10.1038/natur e0295 8 (2004).
 8. Brady, S. N., Yu, Y., Maggi, L. B. & Weber, J. D. ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway. 
Mol. Cell. Biol. 24, 9327–9338. https ://doi.org/10.1128/MCB.24.21.9327-9338.2004 (2004).
 9. Lessard, F. et al. The ARF tumor suppressor controls ribosome biogenesis by regulating the RNA polymerase I transcription factor 
TTF-I. Mol. Cell. 38, 539–550. https ://doi.org/10.1016/j.molce l.2010.03.015 (2010).
 10. Kuchenreuther, M. J. & Weber, J. D. The ARF tumor-suppressor controls Drosha translation to prevent Ras-driven transformation. 
Oncogene 33, 300–307. https ://doi.org/10.1038/onc.2012.601 (2014).
 11. Eymin, B. et al. Human ARF binds E2F1 and inhibits its transcriptional activity. Oncogene 20, 1033–1041. https ://doi.org/10.1038/
sj.onc.12042 20 (2001).
 12. Ayrault, O. et al. Human tumor suppressor p14ARF negatively regulates rRNA transcription and inhibits UBF1 transcription factor 
phosphorylation. Oncogene 25, 7577–7586. https ://doi.org/10.1038/sj.onc.12097 43 (2006).
 13. Dai, M. S. et al. Physical and functional interaction between ribosomal protein L11 and the tumor suppressor ARF. J. Biol. Chem. 
287, 17120–17129. https ://doi.org/10.1074/jbc.M111.31190 2 (2012).
 14. Bertwistle, D., Sugimoto, M. & Sherr, C. J. Physical and functional interactions of the Arf tumor suppressor protein with nucle-
ophosmin/B23. Mol. Cell. Biol. 24, 985–996 (2004).
 15. Saporita, A. J. et al. RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis. Cancer Res. 
71, 6708–6717. https ://doi.org/10.1158/0008-5472.CAN-11-1472 (2011).
 16. Apicelli, A. J. et al. A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function. Mol. Cell. Biol. 
28, 1068–1080. https ://doi.org/10.1128/MCB.00484 -07 (2008).
 17. Kawagishi, H. et al. ARF suppresses tumor angiogenesis through translational control of VEGFA mRNA. Cancer Res. 70, 4749–
4758. https ://doi.org/10.1158/0008-5472.CAN-10-0368 (2010).
 18. Bursac, S., Brdovcak, M. C., Donati, G. & Volarevic, S. Activation of the tumor suppressor p53 upon impairment of ribosome 
biogenesis. Biochim. Biophys. Acta 817–830, 2014. https ://doi.org/10.1016/j.bbadi s.2013.08.014 (1842).
 19. Hasty, P., Sharp, Z. D., Curiel, T. J. & Campisi, J. mTORC1 and p53: Clash of the gods?. Cell Cycle 12, 20–25. https ://doi.org/10.4161/
cc.22912 (2013).
 20. Morita, M. et al. mTOR coordinates protein synthesis, mitochondrial activity and proliferation. Cell Cycle 14, 473–480. https ://
doi.org/10.4161/15384 101.2014.99157 2 (2015).
 21. Yamashita, R. et al. Comprehensive detection of human terminal oligo-pyrimidine (TOP) genes and analysis of their characteristics. 
Nucleic Acids Res. 36, 3707–3715. https ://doi.org/10.1093/nar/gkn24 8 (2008).
 22. Levy, S., Avni, D., Hariharan, N., Perry, R. P. & Meyuhas, O. Oligopyrimidine tract at the 5’ end of mammalian ribosomal pro-
tein mRNAs is required for their translational control. Proc. Natl. Acad. Sci. U.S.A. 88, 3319–3323. https ://doi.org/10.1073/
pnas.88.8.3319 (1991).
 23. Fonseca, B. D. et al. La-related protein 1 (LARP1) represses terminal oligopyrimidine (TOP) mRNA translation downstream of 
mTOR complex 1 (mTORC1). J. Biol. Chem. 290, 15996–16020. https ://doi.org/10.1074/jbc.M114.62173 0 (2015).
 24. Hong, S. et al. LARP1 functions as a molecular switch for mTORC1-mediated translation of an essential class of mRNAs. eLife 6, 
e25237. https ://doi.org/10.7554/eLife .25237 (2017).
 25. Hsieh, A. C. et al. The translational landscape of mTOR signalling steers cancer initiation and metastasis. Nature 485, 55–61. https 
://doi.org/10.1038/natur e1091 2 (2012).
 26. Thoreen, C. C. et al. A unifying model for mTORC1-mediated regulation of mRNA translation. Nature 485, 109–113. https ://doi.
org/10.1038/natur e1108 3 (2012).
 27. Lahr, R. M. et al. La-related protein 1 (LARP1) binds the mRNA cap, blocking eIF4F assembly on TOP mRNAs. Elife 6, 2. https ://
doi.org/10.7554/eLife .24146 (2017).
 28. Tcherkezian, J. et al. Proteomic analysis of cap-dependent translation identifies LARP1 as a key regulator of 5’TOP mRNA transla-
tion. Genes Dev. 28, 357–371. https ://doi.org/10.1101/gad.23140 7.113 (2014).
 29. Miloslavski, R. et al. Oxygen sufficiency controls TOP mRNA translation via the TSC-Rheb-mTOR pathway in a 4E-BP-independ-
ent manner. J. Mol. Cell. Biol. 6, 255–266. https ://doi.org/10.1093/jmcb/mju00 8 (2014).
 30. Kamijo, T. et al. Tumor suppression at the mouse INK4a locus mediated by the alternative reading frame product p19ARF. Cell 
91, 649–659. https ://doi.org/10.1016/s0092 -8674(00)80452 -3 (1997).
 31. Nathans, D. Puromycin inhibition of protein synthesis: Incorporation of puromycin into peptide chains. Proc. Natl. Acad. Sci. 
U.S.A. 51, 585–592. https ://doi.org/10.1073/pnas.51.4.585 (1964).
 32. Chothani, S. et al. deltaTE: Detection of translationally regulated genes by integrative analysis of ribo-seq and RNA-seq data. Curr. 
Protoc. Mol. Biol. 129, e108. https ://doi.org/10.1002/cpmb.108 (2019).
 33. Shima, H. et al. Disruption of the p70(s6k)/p85(s6k) gene reveals a small mouse phenotype and a new functional S6 kinase. EMBO 
J. 17, 6649–6659. https ://doi.org/10.1093/emboj /17.22.6649 (1998).
 34. Jefferies, H. B. et al. Rapamycin suppresses 5’TOP mRNA translation through inhibition of p70s6k. EMBO J. 16, 3693–3704. https 
://doi.org/10.1093/emboj /16.12.3693 (1997).
 35. Tang, H. et al. Amino acid-induced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3-kinase-mediated 
signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation. Mol. Cell. Biol. 21, 8671–8683. 
https ://doi.org/10.1128/MCB.21.24.8671-8683.2001 (2001).
 36. Robichaud, N., Sonenberg, N., Ruggero, D. & Schneider, R. J. Translational Control in Cancer. Cold Spring Harbor Perspect. Biol. 
https ://doi.org/10.1101/cshpe rspec t.a0328 96 (2019).
 37. Haneke, K. et al. CDK1 couples proliferation with protein synthesis. J Cell Biol https ://doi.org/10.1083/jcb.20190 6147 (2020).
 38. Gerashchenko, M. V. et al. Translation elongation factor 2 depletion by siRNA in mouse liver leads to mTOR-independent trans-
lational upregulation of ribosomal protein genes. Sci. Rep. 10, 15473. https ://doi.org/10.1038/s4159 8-020-72399 -4 (2020).
13
Vol.:(0123456789)
Scientific Reports |        (2020) 10:22276  | https://doi.org/10.1038/s41598-020-79379-8
www.nature.com/scientificreports/
 39. Tamarkin-Ben-Harush, A., Vasseur, J. J., Debart, F., Ulitsky, I. & Dikstein, R. Cap-proximal nucleotides via differential eIF4E 
binding and alternative promoter usage mediate translational response to energy stress. Elife https ://doi.org/10.7554/eLife .21907 
(2017).
 40. Schwenzer, H. et al. LARP1 isoform expression in human cancer cell lines. RNA Biol https ://doi.org/10.1080/15476 286.2020.17443 
20 (2020).
 41. Ye, L. et al. Overexpression of LARP1 predicts poor prognosis of colorectal cancer and is expected to be a potential therapeutic 
target. Tumour Biol 37, 14585–14594. https ://doi.org/10.1007/s1327 7-016-5332-3 (2016).
 42. Hopkins, T. G. et al. The RNA-binding protein LARP1 is a post-transcriptional regulator of survival and tumorigenesis in ovarian 
cancer. Nucleic Acids Res 44, 1227–1246. https ://doi.org/10.1093/nar/gkv15 15 (2016).
 43. Silvera, D. et al. Essential role for eIF4GI overexpression in the pathogenesis of inflammatory breast cancer. Nat. Cell. Biol. 11, 
903–908. https ://doi.org/10.1038/ncb19 00 (2009).
 44. Braunstein, S. et al. A hypoxia-controlled cap-dependent to cap-independent translation switch in breast cancer. Mol. Cell. 28, 
501–512. https ://doi.org/10.1016/j.molce l.2007.10.019 (2007).
 45. Cottrell, K. A., Szczesny, P. & Djuranovic, S. Translation efficiency is a determinant of the magnitude of miRNA-mediated repres-
sion. Sci. Rep. 7, 14884. https ://doi.org/10.1038/s4159 8-017-13851 -w (2017).
 46. McGlincy, N. J. & Ingolia, N. T. Transcriptome-wide measurement of translation by ribosome profiling. Methods 126, 112–129. 
https ://doi.org/10.1016/j.ymeth .2017.05.028 (2017).
 47. Hannon, G. J. FASTX-Toolkit (2010).
 48. Smith, T., Heger, A. & Sudbery, I. UMI-tools: Modeling sequencing errors in Unique Molecular Identifiers to improve quantifica-
tion accuracy. Genome Res. 27, 491–499. https ://doi.org/10.1101/gr.20960 1.116 (2017).
 49. Martin, M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 17, 2 (2011).
 50. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359. https ://doi.org/10.1038/nmeth 
.1923 (2012).
 51. Trapnell, C., Pachter, L. & Salzberg, S. L. TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105–1111. https 
://doi.org/10.1093/bioin forma tics/btp12 0 (2009).
 52. Anders, S., Pyl, P. T. & Huber, W. HTSeq–a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 
166–169. https ://doi.org/10.1093/bioin forma tics/btu63 8 (2015).
 53. Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome 
Biol. 15, 550. https ://doi.org/10.1186/s1305 9-014-0550-8 (2014).
 54. Mi, H., Muruganujan, A., Ebert, D., Huang, X. & Thomas, P. D. PANTHER version 14: more genomes, a new PANTHER GO-slim 
and improvements in enrichment analysis tools. Nucleic Acids Res. 47, D419–D426. https ://doi.org/10.1093/nar/gky10 38 (2019).
 55. Ashburner, M. et al. Gene ontology: Tool for the unification of biology. The gene ontology consortium. Nat. Genet. 25, 25–29. 
https ://doi.org/10.1038/75556 (2000).
 56. The Gene Ontology Consortium. The gene ontology resource: 20 years and still GOing strong. Nucleic Acids Res. 47, D330–D338. 
https ://doi.org/10.1093/nar/gky10 55 (2019).
Acknowledgements
We thank Dr. Len Maggi for preparation of MEFs and guidance. This work was supported by: 5T32HL007088-
42 and F32GM131514 to KAC; R01CA190986-03 and DOD W81XWH-15-1-0388 to JDW and the Longer Life 
Foundation: An RGA/Washington University Partnership.
Author contributions
K.A.C. and J.D.W. conceived the project. K.A.C. performed the experiments and data analysis. R.C. generated 
the luciferase reporter constructs. K.A.C. wrote the manuscript. All authors edited the manuscript.
Competing interests 
The authors declare no competing interests.
Additional information
Supplementary Information The online version contains supplementary material available at https ://doi.
org/10.1038/s4159 8-020-79379 -8.
Correspondence and requests for materials should be addressed to J.D.W.
Reprints and permissions information is available at www.nature.com/reprints.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access  This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the 
Creative Commons licence, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from 
the copyright holder. To view a copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
© The Author(s) 2020
